Treatment of oligodendroglioma: an update.

Por Paleologos, N. A., Cairncross, J. G.
Publicado em 1999

Identification of glial filament protein and vimentin in the same intermediate filament system in human glioma cells.

Por Wang, E, Cairncross, J G, Liem, R K
Publicado em 1984

p53‐dependent up‐regulation of CDKN1A and down‐regulation of CCNE2 in response to beryllium

Por Gorjala, P., Cairncross, J. G., Gary, R. K.
Publicado no Cell Prolif (2016)

Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets.

Por Cairncross, J G, Mattes, M J, Beresford, H R, Albino, A P, Houghton, A N, Lloyd, K O, Old, L J
Publicado em 1982

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.

Por Doolittle, N. D., Anderson, C. P., Bleyer, W. A., Cairncross, J. G., Cloughesy, T., Eck, S. L., Guastadisegni, P., Hall, W. A., Muldoon, L. L., Patel, S. J., Peereboom, D., Siegal, T., Neuwelt, E. A.
Publicado em 2001

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain T...

Por Mauer, M, Stupp, R, Taphoorn, M J B, Coens, C, Osoba, D, Marosi, C, Wong, R, de Witte, O, Cairncross, J G, Efficace, F, Mirimanoff, R O, Forsyth, P, van den Bent, M J, Weller, M, Bottomley, A
Publicado em 2007

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma

Por Weller, M., Gorlia, T., Cairncross, J.G., van den Bent, M.J., Mason, W., Belanger, K., Brandes, A.A., Bogdahn, U., Macdonald, D.R., Forsyth, P., Rossetti, A.O., Lacombe, D., Mirimanoff, R.-O., Vecht, C.J., Stupp, R.
Publicado em 2011